v3.25.4
Equity-Based Compensation - Additional Information (Details)
1 Months Ended 12 Months Ended
Nov. 30, 2025
shares
May 31, 2025
shares
Apr. 21, 2025
shares
Nov. 30, 2024
shares
May 31, 2024
shares
Nov. 30, 2023
shares
May 31, 2023
shares
Sep. 30, 2021
USD ($)
Dec. 31, 2025
USD ($)
installment
shares
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Aug. 31, 2025
USD ($)
Dec. 31, 2022
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Stock options, granted (in shares)                 0 0 0    
Unvested option outstanding (in shares)                 7,547,230 9,514,741 13,245,354   17,754,770
Number of installments | installment                 3        
Share repurchase program, authorized amount | $                       $ 100,000,000  
Repurchase of common stock | $                 $ 18,054,000        
Enfusion Inc                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Equity interests issued and issuable (in shares)     28,066,027                    
Class A                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Repurchase and retirement of common stock (in shares)                 966,603        
Repurchase of common stock | $                 $ 18,100,000        
Stock repurchase program, remaining authorized repurchase amount | $                 $ 81,900,000        
Vesting Conditions Based On Continuous Employment                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Stock awards vesting period                 4 years        
First Anniversary                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Stock option vesting rights, percentage                 25.00%        
Shares Vesting Monthly After First Anniversary                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Stock awards vesting period                 3 years        
Stock option vesting rights, percentage                 75.00%        
Options                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Stock awards vesting period                 4 years        
RSUs                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Unrecognized equity-based compensation expense | $                 $ 152,900,000        
Weighted-average period to recognize expense                 2 years 3 months 18 days        
RSUs | Enfusion Inc                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Equity interests issued and issuable (in shares)     1,900,000                    
Time Based RSUs                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Stock awards vesting period                 4 years        
Common Stock | Class A                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
ESPP shares issued (in shares)                 345,942 291,266 337,182    
Repurchase and retirement of common stock (in shares)                 966,603        
Repurchase of common stock | $                 $ 1,000        
2021 Plan | Common Stock                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Number of shares authorized for issuance (in shares)                 57,197,804        
2021 Employee Stock Purchase Plan                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Unrecognized equity-based compensation expense | $                 $ 1,300,000 $ 1,100,000 $ 700,000    
Purchase price as percentage of lower of fair market value as of beginning or end of offering period               85.00%          
Maximum percentage of employee payroll deduction for stock purchase               10.00%          
Maximum value of shares eligible to purchase during offering period | $               $ 25,000          
ESPP shares issued (in shares) 177,032 168,910   117,998 173,268 147,792 189,390            
ESPP payroll contributions | $                 $ 800,000 $ 500,000      
2021 Employee Stock Purchase Plan | Class A                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Common stock were initially reserved for issuance (in shares)                 6,914,977        
2021 Employee Stock Purchase Plan | ESPP of Clearwater Analytics Holdings, Inc.                          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                          
Offering period                 6 months